Jeil Pharmaceutical Co Ltd Free Cash Flow Generation Index

Latest as of December 2025: -3.20x

Jeil Pharmaceutical Co Ltd free cash flow generation index. Jeil Pharmaceutical Co Ltd (271980) has a Free Cash Flow Generation Index of -3.20x as of December 2025. Free cash flow of ₩-1.70 Billion represents -3% of operating cash flow (₩532.03 Million).

FCF Generation Index

-3.20x
Free Cash Flow / Operating CF

Free Cash Flow

₩-1.70 Billion
KRW

Operating Cash Flow

₩532.03 Million
KRW

Capital Expenditures

₩2.23 Billion
KRW

Free Cash Flow Generation Index of Jeil Pharmaceutical Co Ltd (2018–2024)

Free cash flow generation index of Jeil Pharmaceutical Co Ltd from 2018 to 2024. Historical FCF Generation Index trend for Jeil Pharmaceutical Co Ltd across 4 annual periods. See Jeil Pharmaceutical Co Ltd (271980) financial flexibility to measure the company's free cash flow as a share of total liabilities.

Jeil Pharmaceutical Co Ltd Free Cash Flow Generation Index by Year (2018–2024)

Jeil Pharmaceutical Co Ltd free cash flow generation index by year from 2018 to 2024. Year-by-year Free Cash Flow Generation Index for Jeil Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Jeil Pharmaceutical Co Ltd (271980) cash conversion ratio.

Year FCG Index Free Cash Flow (KRW) Operating CF Capital Expenditures YoY Change
2024 -1.06x ₩-3.40 Billion ₩3.21 Billion ₩6.61 Billion ▼ -247.4%
2021 0.72x ₩13.71 Billion ₩19.10 Billion ₩5.34 Billion ▼ -24.6%
2019 0.95x ₩27.56 Billion ₩28.96 Billion ₩1.09 Billion ▲ +82.9%
2018 0.52x ₩11.17 Billion ₩21.45 Billion ₩10.29 Billion —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).